Skip to content

Preliminary Efficacy Observation of Topical Beta-Carotene in Refractory Erosive Oral Lichen Planus: A Single-Arm Exploratory Study

Preliminary Efficacy Observation of Topical Beta-Carotene in Refractory Erosive Oral Lichen Planus: A Single-Arm Exploratory Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127819
Enrollment
Unknown
Registered
2026-07-08
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erosive oral lichen planus

Interventions

Experimental group:Topical beta-carotene gel group

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with erosive OLP by the Department of Dentistry of China Rehabilitation Research Center; 2. A single erosive area of >= 1 square centimeter, or multiple erosive areas with a total area of >= 1 square centimeter, or an erosive area of = 1 square centimeter; 3. The disease course is >= 6 months; 4. There has been repeated recurrence after local treatment with glucocorticoids; 5. Voluntary for follow-up.

Exclusion criteria

Exclusion criteria: 1. Those with a history of severe allergies or specific constitutions (BC); 2. Those who have received systemic treatment within the last 3 months or local treatment within 2 weeks before enrollment; 3. Those with complications such as uncontrolled hypertension, cardiovascular diseases, blood disorders, neurological and mental disorders, or other systemic diseases that require medication; 4. Those with lichenoid lesions caused by amalgam fillings or certain medications; 5. Pregnant women, lactating women, or women of reproductive age who refuse contraception during the study observation period; 6. Oral external flat lentigo lesions; 7. Other oral mucosal diseases.

Design outcomes

Primary

MeasureTime frame
Changes in oral mucosal lesions before and after treatment;

Secondary

MeasureTime frame
Inflammatory cytokine levels;Quality of life and incidence of adverse events;

Countries

China

Contacts

Public ContactWang Xing

Beijing Bo'ai Hospital

1711110402@pku.edu.cn+86 10 87577518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026